Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
16.76
-0.05 (-0.30%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Theravance Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 863 | 948 | 463 | 560 | 755 | 814 | |
| Market Cap Growth | 107.66% | 104.89% | -17.33% | -25.82% | -7.35% | -28.37% | |
| Enterprise Value | 579 | 660 | 416 | 477 | 320 | 1,269 | |
| Last Close Price | 16.76 | 18.71 | 9.41 | 11.24 | 11.22 | 11.05 | |
| PE Ratio | 8.14 | 8.95 | - | - | 0.87 | - | |
| Forward PE | 6.63 | 25.83 | - | - | - | - | |
| PS Ratio | 8.03 | 8.82 | 7.19 | 9.75 | 14.70 | 14.72 | |
| PB Ratio | 2.88 | 3.20 | 2.64 | 2.63 | 1.71 | -2.40 | |
| P/TBV Ratio | 2.91 | 3.20 | 2.64 | 2.63 | 1.71 | - | |
| P/FCF Ratio | 3.62 | 3.98 | - | - | - | - | |
| P/OCF Ratio | 3.62 | 3.97 | - | - | - | - | |
| EV/Sales Ratio | 5.39 | 6.14 | 6.47 | 8.30 | 6.23 | 22.95 | |
| EV/FCF Ratio | 2.43 | 2.77 | - | - | - | - | |
| Debt / Equity Ratio | 0.14 | 0.14 | 0.28 | 0.23 | 0.12 | -1.98 | |
| Debt / FCF Ratio | 0.18 | 0.18 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.96 | -0.96 | -0.22 | -0.25 | -0.62 | -1.46 | |
| Net Debt / EBITDA Ratio | 143.61 | 143.61 | 0.95 | 1.03 | 3.62 | -2.13 | |
| Net Debt / FCF Ratio | -1.19 | -1.19 | 3.25 | 1.81 | 1.47 | -2.35 | |
| Asset Turnover | 0.26 | 0.26 | 0.18 | 0.12 | 0.11 | 0.13 | |
| Quick Ratio | 10.73 | 10.73 | 4.89 | 4.84 | 11.99 | 3.20 | |
| Current Ratio | 10.93 | 10.93 | 5.02 | 5.39 | 12.31 | 4.26 | |
| Return on Equity (ROE) | 44.84% | 44.84% | -29.04% | -16.86% | -179.84% | - | |
| Return on Assets (ROA) | -0.54% | -0.54% | -7.21% | -6.78% | -10.07% | -35.20% | |
| Return on Invested Capital (ROIC) | - | -3.66% | -28.60% | -32.89% | -48.85% | -200.50% | |
| Return on Capital Employed (ROCE) | -0.80% | -0.80% | -13.20% | -15.00% | -13.70% | -75.10% | |
| Earnings Yield | 12.27% | 11.17% | -12.19% | -9.86% | 115.58% | -24.49% | |
| FCF Yield | 27.64% | 25.16% | -2.56% | -5.27% | -24.86% | -25.94% | |
| Buyback Yield / Dilution | -5.45% | -5.45% | 11.67% | 24.85% | -5.95% | -11.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.